01 1Apicore Pharmaceuticals Private Limited
02 1Heraeus Precious Metals GmbH & Co. KG
01 1DACARBAZINE
02 1Dacarbazine
01 1Germany
02 1India
NDC Package Code : 42973-149
Start Marketing Date : 2011-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54875-0003
Start Marketing Date : 2013-05-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Dacarbazine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dacarbazine, including repackagers and relabelers. The FDA regulates Dacarbazine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dacarbazine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dacarbazine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dacarbazine supplier is an individual or a company that provides Dacarbazine active pharmaceutical ingredient (API) or Dacarbazine finished formulations upon request. The Dacarbazine suppliers may include Dacarbazine API manufacturers, exporters, distributors and traders.
click here to find a list of Dacarbazine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dacarbazine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dacarbazine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dacarbazine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dacarbazine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dacarbazine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dacarbazine suppliers with NDC on PharmaCompass.
We have 2 companies offering Dacarbazine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
